cart33
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2013 (NCT01864902)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Myeloid cell surface antigen CD33Immunity, passive
CD33 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cart33
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05945849 | Phase 1 | Dec 1, 2023 | University of Pennsylvania |
| NCT01864902 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2013 | People's Liberation Army of China |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| People's Liberation Army of China | Government | 1 | 1 | 1 | 2013 |
| University of Pennsylvania | Academic/Hospital | 1 | 1 | 1 | 2023 |
2 organizations
Page 1 / 1